Stay up to date with news and events

A spoonful of branaplam helps the huntingtin go down

April 21, 2022

Scientists at Novartis and The Children’s Hospital of Philadelphia have recently published a paper detailing how the drug branaplam, originally developed for the neurological disease…

Huntington’s disease therapeutics conference 2022 – Day 3

Good morning! Today is the 3rd and final day of the #CHDI HD Therapeutics Conference in Palm Springs. Follow our feed today to get live…

Huntington’s disease therapeutics conference 2022 – Day 1

Good morning from sunny Palm Springs! After a 2-year hiatus because of COVID, the HD Therapeutics Conference is back in person this year – the…

Huntington’s disease therapeutics conference 2022 – Day 2

Good morning and welcome to Day 2 of HDBuzz coverage of the CHDI HD Therapeutics conference! Innovative approaches for HD therapeutics Chairing the third session…

Shining a spotlight on huntingtin: a tool to measure huntingtin-lowering in real time

A recent addition to the Huntington’s disease research toolkit lets us “see” how well huntingtin lowering drugs are working in the brains of HD animal…

1 2